MKSAP 17 Audio Companion - Nephrology

• MKSAP_17_Audio_Companion_Nephrology.pdf
• 1-01 Introduction to Nephrology Section.m4a
• 1-02 Assessment of Kidney Function.m4a
• 1-03 Methods for Estimating Kidney Function.m4a
• 1-04 Estimation of Glomerular Filtration Rate.m4a
• 1-05 Interpretation of the Urinalysis.m4a
• 1-06 Session MCQ 1 Item 2 A 74-year-old Woman is Evaluated for Painless Gross Hematuria.m4a
• 1-07 Additional Findings on Urinalysis.m4a
• 1-08 Urine Microscopy.m4a
• 1-09 Casts and Crystals.m4a
• 1-10 Session MCQ 2 Item 7 A 55-year-old Woman is Evaluated for Persistent Hyperkalemia.m4a
• 1-11 Measurement of Albumin and Protein Excretion.m4a
• 1-12 Clinical Evaluation of Hematuria.m4a
• 1-13 Imaging Used in the Evaluation of Hematuria.m4a
• 1-14 Imaging Studies.m4a
• 1-15 Kidney Biopsy.m4a
• 1-16 Session 1 Key Points.m4a
• 1-17 Close to Session 1.m4a
• 2-01 Introduction to Session 2.m4a
• 2-02 Osmolality and Tonicity.m4a
• 2-03 Disorders of Serum Sodium.m4a
• 2-04 Hypovolemic Hyponatremia.m4a
• 2-05 Hypervolemic Hyponatremia and Euvolemic Hyponatremia.m4a
• 2-06 Clinical Presentation and Management.m4a
• 2-07 Session MCQ 3 Item 10 A 51-year-old Man is Seen for Hypertension and Diabetes.m4a
• 2-08 Acute Symptomatic Hyponatremia and Chronic Hyponatremia.m4a
• 2-09 Hypernatremia.m4a
• 2-10 Evaluation and Management.m4a
• 2-11 Hypokalemia.m4a
• 2-12 Management.m4a
• 2-13 Session MCQ 4 Item 11 A 73-year-old Man with Gradual Weight Gain is Seen.m4a
• 2-14 Hyperkalemia.m4a
• 2-15 Management.m4a
• 2-16 Hypophosphatemia.m4a
• 2-17 Hyperphosphatemia.m4a
• 2-18 Acid-Base Disorders.m4a
• 2-19 General Approach to Metabolic Acidosis.m4a
• 2-20 Session 2 Key Points.m4a
• 2-21 Close to Session 2.m4a
• 3-01 Introduction to Session 3.m4a
• 3-02 Increased Anion Gap Metabolic Acidosis.m4a
• 3-03 Normal Anion Gap Metabolic Acidosis.m4a
• 3-04 Renal Tubular Acidosis.m4a
• 3-05 Mixed Forms of Renal Tubular Acidosis.m4a
• 3-06 Metabolic Alkalosis.m4a
• 3-07 Session MCQ 5 Item 16 A 36-year-old Man with a Second Episode of Nephrolithiasis is Seen.m4a
• 3-08 Respiratory Acidosis.m4a
• 3-09 Respiratory Alkalosis.m4a
• 3-10 Hypertension.m4a
• 3-11 Clinical Impact.m4a
• 3-12 Session MCQ 6 Item 17 A 45-year-old Man with Difficult-to-Control Hypertension and Type 2 Diabetes is Seen.m4a
• 3-13 Blood Pressure Measurement.m4a
• 3-14 Evaluation of the Patient with Newly Diagnosed Hypertension.m4a
• 3-15 Classification of Hypertension.m4a
• 3-16 General Approach to Management.m4a
• 3-17 Session 3 Key Points.m4a
• 3-18 Close to Session 3.m4a
• 4-01 Introduction to Session 4.m4a
• 4-02 Pharmacologic Therapy.m4a
• 4-03 Frequently Used Antihypertensive Medications.m4a
• 4-04 Combination Therapy.m4a
• 4-05 White Coat, Masked and Resistant Hypertension.m4a
• 4-06 Session MCQ 7 Item 18 An 85-year-old Man is Seen for End-Stage Kidney Disease Management.m4a
• 4-07 Secondary Hypertension.m4a
• 4-08 Renovascular Hypertension.m4a
• 4-09 Hypokalemia and Pheochromocytoma.m4a
• 4-10 Special Populations.m4a
• 4-11 Session MCQ 8 Item 21 A 65-year-old Man is Hospitalized for an Ischemic, Nonhealing Lower Extremity Ulcer.m4a
• 4-12 Chronic Tubulointerstitial Diseases.m4a
• 4-13 Diagnosis and Evaluation.m4a
• 4-14 Causes of Chronic Tubulointerstitial Diseases.m4a
• 4-15 Medications.m4a
• 4-16 Session 4 Key Points.m4a
• 4-17 Close to Session 4.m4a
• 5-01 Introduction to Session 5.m4a
• 5-02 Glomerular Diseases.m4a
• 5-03 Clinical Manifestations of Glomerular Disease.m4a
• 5-04 The Nephrotic and Nephritic Syndromes.m4a
• 5-05 Focal Segmental Glomerulosclerosis.m4a
• 5-06 Session MCQ 9 Item 22 A 59-year-old Man is Evaluated for End-Stage Kidney Disease and Hypertension.m4a
• 5-07 Membranous Glomerulopathy.m4a
• 5-08 Minimal Change Glomerulopathy.m4a
• 5-09 Diabetic Nephropathy.m4a
• 5-10 Session MCQ 10 Item 25 A 46-year-old Woman is Seen for Fatigue and Weakness.m4a
• 5-11 Conditions Associated With the Nephritic Syndrome.m4a
• 5-12 Rapidly Progressive Glomerulonephritis.m4a
• 5-13 Anti-Glomerular Basement Membrane Antibody Disease.m4a
• 5-14 Pauci-Immune Glomerulonephritis.m4a
• 5-15 IgA Nephropathy.m4a
• 5-16 Lupus Nephritis.m4a
• 5-17 Infection-Related Glomerulonephritis.m4a
• 5-18 Membranoproliferative Glomerulonephritis.m4a
• 5-19 Session 5 Key Points.m4a
• 5-20 Close to Session 5.m4a
• 6-01 Introduction to Session 6.m4a
• 6-02 Kidney Manifestations of Gammopathies.m4a
• 6-03 Monoclonal Immunoglobulin Deposition Disease and Multiple Myeloma.m4a
• 6-04 Cryoglobulinemia, Fibrillary and Immunotactoid Glomerulonephritis.m4a
• 6-05 Cystic Kidney Disorders.m4a
• 6-06 Clinical Manifestations and Management.m4a
• 6-07 Tuberous Sclerosis Complex.m4a
• 6-08 Session MCQ 11 Item 26 A 77-year-old Woman is Seen After a Cerebral Artery Ischemic Stroke.m4a
• 6-09 Noncystic Kidney Disorders.m4a
• 6-10 Acute Kidney Injury.m4a
• 6-11 Session MCQ 12 Item 27 A 60-year-old Man is Seen for Chronic Kidney Disease due to Membranous Glomerulopathy.m4a
• 6-12 Diagnosis.m4a
• 6-13 Causes of AKI.m4a
• 6-14 Ischemic and Drug-Induced Acute Tubular Necrosis.m4a
• 6-15 Pigment Nephropathy.m4a
• 6-16 Session 6 Key Points.m4a
• 6-17 Close to Session 6.m4a
• 7-01 Introduction to Session 7.m4a
• 7-02 Acute Interstitial Nephritis.m4a
• 7-03 Acute Glomerulonephritis and Acute Vascular Syndromes.m4a
• 7-04 Intratubular Obstruction.m4a
• 7-05 Postrenal Disease.m4a
• 7-06 Contrast-Induced Nephropathy and Cardiorenal Syndrome.m4a
• 7-07 Hepatorenal Syndrome and Tumor Lysis Syndrome.m4a
• 7-08 Abdominal Compartment Syndrome.m4a
• 7-09 Management of AKI.m4a
• 7-10 Kidney Stones.m4a
• 7-11 Types of Kidney Stones.m4a
• 7-12 Struvite, Uric Acid and Cystine Stones.m4a
• 7-13 Management.m4a
• 7-14 Risk Factor Evaluation and Prevention Strategies.m4a
• 7-15 The Kidney in Pregnancy.m4a
• 7-16 Hypertension in Pregnancy.m4a
• 7-17 Preeclampsia.m4a
• 7-18 Session 7 Key Points.m4a
• 7-19 Close to Session 7.m4a
• 8-01 Introduction to Session 8.m4a
• 8-02 Chronic Kidney Disease in Pregnancy.m4a
• 8-03 Chronic Kidney Disease.m4a
• 8-04 Pathophysiology, Screening and Diagnosis.m4a
• 8-05 Complications and Management.m4a
• 8-06 Chronic Kidney Disease-Mineral and Bone Disorder.m4a
• 8-07 Vascular Calcification and Others.m4a
• 8-08 Management.m4a
• 8-09 Anemia and Metabolic Acidosis.m4a
• 8-10 Nephrotoxins and Proteinuria.m4a
• 8-11 Vaccination and Vascular Access.m4a
• 8-12 End-Stage Kidney Disease.m4a
• 8-13 Dialysis.m4a
• 8-14 Kidney Transplantation.m4a
• 8-15 Risks of Transplantation.m4a
• 8-16 Special Considerations in Transplant Recipients.m4a
• 8-17 Cardiovascular Disease and Bone Disease.m4a
• 8-18 Risks of Kidney Donation.m4a
• 8-19 Complications of End-Stage Kidney Disease.m4a
• 8-20 Session 8 Key Points.m4a
• 8-21 Close to Nephrology Section.m4a